There was, however, one shining exception: The two days my new family spent at the Ahma & Co postnatal retreat at the Waldorf ...

Sage Therapeutics reviews Biogen's $7.22 per share acquisition proposal amid ongoing restructuring and focus on Zurzuvae for postpartum depression.

A Boston-based customer engineer at Google said splitting up her leave and three other steps smoothed her postpartum return ...

The University of Virginia's Dr. Anita Clayton has been a primary investigator for nearly every antidepressant approved in ...

Cesarean delivery-related obstetric factors may increase the risk for postpartum depression, including severe postoperative ...

Medically reviewed by Dakari Quimby, PhD Male postpartum depression describes when a new father experiences postpartum ...

Sage Therapeutics, Inc. (Nasdaq: SAGE) saw its stock price soar by an impressive 33.87%, reaching $7.43 during Monday’s premarket trading session. The surge came on the heels of the company’s ...

Kylie welcomed her first child, daughter Wyatt, with husband Jason Kelce in October 2019. They later welcomed daughters Ellie ...

Postpartum depression is not exclusive to women; 10% of new dads also experience it, yet it remains largely overlooked.

Biogen’s proposed acquisition comes after two difficult years of regulatory and clinical challenges, during which shares of ...

In her latest book, the former child star addresses expectations that women never age — especially if they are in the public ...

Are they addictive? No. Are they underprescribed? Yes. The chair of the Department of Psychiatry and Neurobehavioral Sciences ...